FI117159B - Sterolijohdosten käyttö meioosin säätelyyn - Google Patents

Sterolijohdosten käyttö meioosin säätelyyn Download PDF

Info

Publication number
FI117159B
FI117159B FI965144A FI965144A FI117159B FI 117159 B FI117159 B FI 117159B FI 965144 A FI965144 A FI 965144A FI 965144 A FI965144 A FI 965144A FI 117159 B FI117159 B FI 117159B
Authority
FI
Finland
Prior art keywords
use according
hydrogen
carbon atoms
attached
together represent
Prior art date
Application number
FI965144A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI965144A0 (fi
FI965144A (fi
Inventor
Erling Guddal
Claus Yding Andersen
Anne Grete Byskov
Lars Nordholm
Henning Thoegersen
Ole Wassmann
Ivan Verner Diers
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI965144A0 publication Critical patent/FI965144A0/fi
Publication of FI965144A publication Critical patent/FI965144A/fi
Application granted granted Critical
Publication of FI117159B publication Critical patent/FI117159B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI965144A 1994-06-23 1996-12-20 Sterolijohdosten käyttö meioosin säätelyyn FI117159B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK75394 1994-06-23
DK75394 1994-06-23
DK24195 1995-03-09
DK24195 1995-03-09
PCT/DK1995/000265 WO1996000235A1 (en) 1994-06-23 1995-06-23 Sterol derivatives used for regulation of meiosis
DK9500265 1995-06-23

Publications (3)

Publication Number Publication Date
FI965144A0 FI965144A0 (fi) 1996-12-20
FI965144A FI965144A (fi) 1997-02-20
FI117159B true FI117159B (fi) 2006-07-14

Family

ID=26063596

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965144A FI117159B (fi) 1994-06-23 1996-12-20 Sterolijohdosten käyttö meioosin säätelyyn

Country Status (26)

Country Link
US (1) US5716777A (da)
EP (1) EP0767798B1 (da)
JP (1) JP3987105B2 (da)
KR (1) KR100408369B1 (da)
CN (1) CN1068333C (da)
AT (1) ATE248852T1 (da)
AU (1) AU694240B2 (da)
BG (1) BG101067A (da)
BR (1) BR9508074A (da)
CA (1) CA2192941C (da)
CZ (1) CZ289407B6 (da)
DE (1) DE69531682T2 (da)
DK (1) DK0767798T3 (da)
ES (1) ES2204955T3 (da)
FI (1) FI117159B (da)
HU (1) HUT76343A (da)
IL (1) IL114294A (da)
IS (1) IS4404A (da)
MX (1) MX9700174A (da)
NO (1) NO314534B1 (da)
PL (1) PL186688B1 (da)
RU (1) RU2194510C2 (da)
SI (1) SI9520077A (da)
SK (1) SK165596A3 (da)
UA (1) UA51622C2 (da)
WO (1) WO1996000235A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980702624A (ko) * 1995-03-06 1998-08-05 슈타르 피아 감수분열의 자극
CA2224866A1 (en) * 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
US6645953B2 (en) * 1995-06-23 2003-11-11 Novo Nordisk A/S Meiosis regulating compounds
WO1997000883A1 (en) * 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
AU746878B2 (en) 1996-12-20 2002-05-02 Novo Nordisk A/S Meiosis regulating compounds
KR20010012643A (ko) * 1997-05-16 2001-02-26 에프.지.엠. 헤르만스 20-아랄킬-5α-프레그난 유도체
EP0988312B1 (en) * 1997-06-04 2002-04-03 Akzo Nobel N.V. 17beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
WO1999032506A1 (en) * 1997-12-18 1999-07-01 Akzo Nobel N.V. 17β-ARYL (ARYLMETHYL) OXY(THIO)ALKYL -ANDROSTANE DERIVATIVES
BR9910415A (pt) * 1998-05-13 2001-01-09 Novo Nordisk As Novos compostos, uso de compostos, e, processo de regular a meiose
IL139241A0 (en) 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
EP1098652A2 (en) * 1998-05-26 2001-05-16 Schering Aktiengesellschaft Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
JP2003521444A (ja) * 1998-06-19 2003-07-15 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
DK1137660T3 (da) * 1998-12-11 2003-02-03 Akzo Nobel Nv 22S-hydroxycholesta-8,14-dienderivater med meioseregulerende aktivitet
WO2000036132A1 (en) 1998-12-14 2000-06-22 Merck & Co., Inc. Hiv integrase inhibitors
WO2000047604A1 (en) * 1999-02-10 2000-08-17 Schering Aktiengesellschaft Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
EP1156822B1 (en) 1999-02-24 2006-02-08 Novo Nordisk A/S Iin vitro method for synchronisation of oocyte maturation
DE60034662T2 (de) * 1999-02-24 2008-01-03 Novo Nordisk A/S Behandlung von unfruchtbarkeit
JP2002537801A (ja) * 1999-02-26 2002-11-12 ノボ ノルディスク アクティーゼルスカブ 着床率を増大させる減数分裂活性化ステロール
EP1163258B1 (en) * 1999-03-09 2002-12-11 Akzo Nobel N.V. 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
WO2001019354A2 (en) * 1999-09-16 2001-03-22 Novo Nordisk A/S Composition for ivf
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
WO2001062260A2 (en) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate
AU2001240624A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Improvement of implantation rate
JP2003533222A (ja) * 2000-05-18 2003-11-11 シエーリング アクチエンゲゼルシャフト 経年卵母細胞の受精
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
WO2003070766A2 (en) * 2002-02-22 2003-08-28 Novo Nordisk A/S A transducer of mas signalling
US9376462B2 (en) 2010-10-01 2016-06-28 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from Ganoderma lucidum and analogs thereof
US9165822B2 (en) 2013-03-11 2015-10-20 Taiwan Semiconductor Manufacturing Company, Ltd. Semiconductor devices and methods of forming same
EA024619B1 (ru) * 2014-11-21 2016-10-31 Эльвин Гаджи оглы Керимли ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ

Also Published As

Publication number Publication date
CZ289407B6 (cs) 2002-01-16
IL114294A0 (en) 1995-10-31
NO314534B1 (no) 2003-04-07
AU694240B2 (en) 1998-07-16
SK165596A3 (en) 1997-08-06
NO965516D0 (no) 1996-12-20
IL114294A (en) 2002-09-12
EP0767798B1 (en) 2003-09-03
ES2204955T3 (es) 2004-05-01
MX9700174A (es) 1997-04-30
FI965144A0 (fi) 1996-12-20
HUT76343A (en) 1997-08-28
US5716777A (en) 1998-02-10
IS4404A (is) 1996-12-23
HU9603584D0 (en) 1997-02-28
SI9520077A (sl) 1998-06-30
EP0767798A1 (en) 1997-04-16
KR100408369B1 (ko) 2004-04-28
UA51622C2 (uk) 2002-12-16
CA2192941C (en) 2009-04-14
WO1996000235A1 (en) 1996-01-04
FI965144A (fi) 1997-02-20
BR9508074A (pt) 1997-08-12
DE69531682T2 (de) 2004-07-15
AU2734395A (en) 1996-01-19
CZ372596A3 (en) 1997-07-16
JPH10502060A (ja) 1998-02-24
CN1068333C (zh) 2001-07-11
RU2194510C2 (ru) 2002-12-20
DK0767798T3 (da) 2003-12-22
JP3987105B2 (ja) 2007-10-03
CA2192941A1 (en) 1996-01-04
PL186688B1 (pl) 2004-02-27
PL317830A1 (en) 1997-04-28
BG101067A (en) 1997-08-29
DE69531682D1 (de) 2003-10-09
ATE248852T1 (de) 2003-09-15
CN1151164A (zh) 1997-06-04
NO965516L (no) 1997-02-21

Similar Documents

Publication Publication Date Title
FI117159B (fi) Sterolijohdosten käyttö meioosin säätelyyn
EP0857173B1 (en) Meiosis regulating compounds
EP0946584B1 (en) Meiosis regulating compounds
US20030004148A1 (en) Regulation of meiosis
KR20020013541A (ko) 14β-Ｈ-스테롤, 그를 포함하는 제약 조성물, 및 감수분열조절 약제 제조에 있어서 그의 유도체의 용도
KR20010101820A (ko) 불포화 콜레스탄 유도체 및 감수분열 조절 약제 제조에있어서 그의 용도
MXPA98000123A (en) Compounds that regulate the meio
JP2002532511A (ja) 減数分裂調節活性を有する２２ｓ−ヒドロキシコレスタ−８，１４−ジエン誘導体
CZ291308B6 (cs) Sterolové deriváty regulující meiózu a způsob regulace

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117159

Country of ref document: FI